期刊文献+

雷珠单抗联合激光治疗视网膜分支静脉阻塞所致黄斑水肿的临床研究 被引量:14

A Clinical Study of Lucentis Combined with Laser Therapy in the Treatment of Macular Edema Caused by Branch Retinal Vein Occlusion
在线阅读 下载PDF
导出
摘要 目的探讨雷珠单抗联合激光治疗视网膜分支静脉阻塞所致黄斑水肿的临床疗效和安全性。方法将135例(144眼)RVO合并黄斑水肿患者按就诊顺序1∶1∶1随机分为3组,A组采用雷珠单抗联合激光治疗治疗,B组采用单纯激光治疗,C组采用单纯雷珠单抗注射治疗,比较各组疗效、视力变化和安全性。结果 A组有效率87.50%,B、C组有效率均为64.58%,差异有统计学意义(Ridit z=16.578,P=0.000);治疗后,3组患者视力均有提高,与治疗前相比差异有统计学意义(P<0.05),治疗后各组患者视力差异有统计学意义(P<0.05),A组视力优于B、C组。结论雷珠单抗联合激光治疗组可以尽快消除黄斑水肿,保护中心视力。 Objective To investigate the clinical efficacy and safety of lucentis combined with laser therapy in the treatment of macular edema caused by branch retinal vein occlusion. Methods 135 patients (144 eyes) with RVO and macular edema were randomly divided into 3 groups in accordance with the visiting sequence and the ratio of 1:1:1. Patients of A group were given treatment of lucentis combined with laser therapy; patients of B group were given pure laser treatment and patients of C group were given pure lucentis treatment. The clinical effect, vision changes and safety of three groups were compared. Results The total ef- fective rate of A group, B group and C group respectively was 87.50%, 64.58%, 64.58%, and the differences had statistical signifi- cance (Ridit z=16.578,P=0.000). Compared with before treatment, the visions of 3 groups all increased, and the differences in groups had statistical significance (P〈0.05);after treatment, the vision of A group was better than that of B group and C group and the differences among groups also had statistical significance (P〈0.05). Conclusion Lucentis combined with laser therapy can e- liminate macular edema as soon as possible and protect central vision.
作者 王淑静
出处 《中外医疗》 2013年第35期16-17,共2页 China & Foreign Medical Treatment
关键词 雷珠单抗 黄斑水肿 激光治疗 疗效 Lucentis Macular Edema Laser therapy Clinical Effect
作者简介 王淑静(1980.12-),女,山东聊城人,本科,主治医师,研究方向:眼底病。
  • 相关文献

参考文献5

二级参考文献31

共引文献23

同被引文献87

  • 1赵明威,胡庆军,黎晓新.玻璃体内注射曲安奈德治疗黄斑水肿临床研究的现状分析[J].中华眼底病杂志,2005,21(4):220-223. 被引量:24
  • 2齐慧君,黎晓新.糖尿病性黄斑水肿的激光治疗[J].眼科,2005,14(4):234-236. 被引量:35
  • 3吕沛霖,李英泰,朱秀萍,赵燕麟,赵俊宏.药物过敏史患者250例眼底荧光血管造影不良反应临床分析[J].国际眼科杂志,2005,5(5):1061-1063. 被引量:12
  • 4张惠蓉,王欣,鹿新荣,杨艳芳,刘峰.视网膜静脉阻塞致黄斑水肿患者相干光断层扫描和视力预后观察[J].中华眼科杂志,2005,41(10):910-916. 被引量:45
  • 5Funatsu H,Yamashita H,Sakata K,et al.Vitreous levels of vas- cular endothelial growthfactor and intracellular adhesion mole- cule 1 are related to diabetic macular edema[J]. Ophthalmolo- gy, 2005,112(5) :806-816.
  • 6Wang H, Sun X, Liu K, et al.Intravitreal ranibizumab(lucentis) for the treatment of diabetic macular edema: a systematic re- view and metaanalysis of randomized clinical control trials[J]. Curt Eye Res,2012,37(8):661-670.
  • 7Ferrara N,Damieo L,Shams N,et al. Development of Ranibizum- ab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovaseular age-related macular degener- ation [ J ].Retina, 2006,26(8) : 859-870.
  • 8Early Teratment Diabetic Rretinopathy Study Reserch Group. Treanment techniques and clinical guidelines for photocogagula- tion of diabetic macular edema. Early teratment of diabetic reti- nopathy study Report Number 2 [J]. Ophthalmology, 1987.94 (7) :761-774.
  • 9Antonetti DA, Barber A J, Khin S. et al. Vascular permeabilityin experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells.penn state retina research group[J]. Diabetes, 1998,47(12) : 1953-1959.
  • 10Early Teratment Diabetic Rretinopathy Study Reserch Group. Treanment techniques and clinical guidelines for photocogagula- tiou of diabetic macular edema. Early teratment of diabetic reti- nopathy study report number l[J]. Arch Ophthalmol, 1985, 103 (12) : 1796-1806.

引证文献14

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部